Vertex Pharmaceuticals (NASDAQ: VRTX) topped market expectations on revenue and earnings for the first quarter of 2019. Shares were up 1.7% in
Vertex Pharmaceuticals Incorporated
-(VRTX)
XNAS:VRTX
Moderna raises over $600-million through IPO, falls below IPO price
Biotech company Moderna raised above $600 million on Thursday by selling about 26 million of its common stock at $23 a share,